Skip to main content
. 2014 Oct 6;8:1709–1721. doi: 10.2147/DDDT.S65678

Figure 5.

Figure 5

Figure 5

Mean concentration–time profiles of (A) plasma glucagon-like peptide-1 (GLP-1), (B) serum glucose, and (C) whole blood insulin after multiple doses of placebo or evogliptin (5, 10, or 20 mg).